1
|
Mitrotti A, Di Bari I, Giliberti M, Franzin R, Conserva F, Chiusolo A, Gigante M, Accetturo M, Cafiero C, Ricciato L, Stea ED, Forleo C, Gallone A, Rossini M, Fiorentino M, Castellano G, Pontrelli P, Gesualdo L. What Is Hidden in Patients with Unknown Nephropathy? Genetic Screening Could Be the Missing Link in Kidney Transplantation Diagnosis and Management. Int J Mol Sci 2024; 25:1436. [PMID: 38338714 PMCID: PMC10855929 DOI: 10.3390/ijms25031436] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2023] [Revised: 01/15/2024] [Accepted: 01/16/2024] [Indexed: 02/12/2024] Open
Abstract
Between 15-20% of patients with end stage renal disease (ESRD) do not know the cause of the primary kidney disease and can develop complications after kidney transplantation. We performed a genetic screening in 300 patients with kidney transplantation, or undiagnosed primary renal disease, in order to identify the primary disease cause and discriminate between overlapping phenotypes. We used a custom-made panel for next-generation sequencing (Agilent technology, Santa Clara, CA, USA), including genes associated with Fabry disease, podocytopaties, complement-mediated nephropathies and Alport syndrome-related diseases. We detected candidate diagnostic variants in genes associated with nephrotic syndrome and Focal Segmental Glomerulosclerosis (FSGS) in 29 out of 300 patients, solving about 10% of the probands. We also identified the same genetic cause of the disease (PAX2: c.1266dupC) in three family members with different clinical diagnoses. Interestingly we also found one female patient carrying a novel missense variant, c.1259C>A (p.Thr420Lys), in the GLA gene not previously associated with Fabry disease, which is in silico defined as a likely pathogenic and destabilizing, and associated with a mild alteration in GLA enzymatic activity. The identification of the specific genetic background may provide an opportunity to evaluate the risk of recurrence of the primary disease, especially among patient candidates living with a donor kidney transplant.
Collapse
Affiliation(s)
- Adele Mitrotti
- Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy; (A.M.); (I.D.B.); (M.G.); (R.F.); (F.C.); (A.C.); (M.G.); (M.A.); (C.C.); (L.R.); (E.D.S.); (C.F.); (M.R.); (M.F.)
| | - Ighli Di Bari
- Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy; (A.M.); (I.D.B.); (M.G.); (R.F.); (F.C.); (A.C.); (M.G.); (M.A.); (C.C.); (L.R.); (E.D.S.); (C.F.); (M.R.); (M.F.)
| | - Marica Giliberti
- Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy; (A.M.); (I.D.B.); (M.G.); (R.F.); (F.C.); (A.C.); (M.G.); (M.A.); (C.C.); (L.R.); (E.D.S.); (C.F.); (M.R.); (M.F.)
| | - Rossana Franzin
- Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy; (A.M.); (I.D.B.); (M.G.); (R.F.); (F.C.); (A.C.); (M.G.); (M.A.); (C.C.); (L.R.); (E.D.S.); (C.F.); (M.R.); (M.F.)
| | - Francesca Conserva
- Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy; (A.M.); (I.D.B.); (M.G.); (R.F.); (F.C.); (A.C.); (M.G.); (M.A.); (C.C.); (L.R.); (E.D.S.); (C.F.); (M.R.); (M.F.)
| | - Anna Chiusolo
- Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy; (A.M.); (I.D.B.); (M.G.); (R.F.); (F.C.); (A.C.); (M.G.); (M.A.); (C.C.); (L.R.); (E.D.S.); (C.F.); (M.R.); (M.F.)
| | - Maddalena Gigante
- Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy; (A.M.); (I.D.B.); (M.G.); (R.F.); (F.C.); (A.C.); (M.G.); (M.A.); (C.C.); (L.R.); (E.D.S.); (C.F.); (M.R.); (M.F.)
| | - Matteo Accetturo
- Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy; (A.M.); (I.D.B.); (M.G.); (R.F.); (F.C.); (A.C.); (M.G.); (M.A.); (C.C.); (L.R.); (E.D.S.); (C.F.); (M.R.); (M.F.)
| | - Cesira Cafiero
- Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy; (A.M.); (I.D.B.); (M.G.); (R.F.); (F.C.); (A.C.); (M.G.); (M.A.); (C.C.); (L.R.); (E.D.S.); (C.F.); (M.R.); (M.F.)
| | - Luisa Ricciato
- Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy; (A.M.); (I.D.B.); (M.G.); (R.F.); (F.C.); (A.C.); (M.G.); (M.A.); (C.C.); (L.R.); (E.D.S.); (C.F.); (M.R.); (M.F.)
| | - Emma Diletta Stea
- Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy; (A.M.); (I.D.B.); (M.G.); (R.F.); (F.C.); (A.C.); (M.G.); (M.A.); (C.C.); (L.R.); (E.D.S.); (C.F.); (M.R.); (M.F.)
| | - Cinzia Forleo
- Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy; (A.M.); (I.D.B.); (M.G.); (R.F.); (F.C.); (A.C.); (M.G.); (M.A.); (C.C.); (L.R.); (E.D.S.); (C.F.); (M.R.); (M.F.)
| | - Anna Gallone
- Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari Aldo Moro, 70121 Bari, Italy;
| | - Michele Rossini
- Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy; (A.M.); (I.D.B.); (M.G.); (R.F.); (F.C.); (A.C.); (M.G.); (M.A.); (C.C.); (L.R.); (E.D.S.); (C.F.); (M.R.); (M.F.)
| | - Marco Fiorentino
- Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy; (A.M.); (I.D.B.); (M.G.); (R.F.); (F.C.); (A.C.); (M.G.); (M.A.); (C.C.); (L.R.); (E.D.S.); (C.F.); (M.R.); (M.F.)
| | - Giuseppe Castellano
- Department of Clinical Sciences and Community Health, University of Milano, 20122 Milano, Italy;
- Fondazione IRCCS Cà Grande Ospedale Maggiore Policlinico, 20122 Milano, Italy
| | - Paola Pontrelli
- Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy; (A.M.); (I.D.B.); (M.G.); (R.F.); (F.C.); (A.C.); (M.G.); (M.A.); (C.C.); (L.R.); (E.D.S.); (C.F.); (M.R.); (M.F.)
| | - Loreto Gesualdo
- Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy; (A.M.); (I.D.B.); (M.G.); (R.F.); (F.C.); (A.C.); (M.G.); (M.A.); (C.C.); (L.R.); (E.D.S.); (C.F.); (M.R.); (M.F.)
| |
Collapse
|